Correlation of focal neuroendocrine differentiation in prostate cancer with the parameters of predictive value

Correlation of focal neuroendocrine differentiation in prostate cancer with the parameters of predictive value

Background/Aim. Neuroendocrine (NE) cells are one of the epithelial populations in the prostate. It is well-known that the focal neuroendocrine differentiation (FNED) in prostate cancer (PC) is an aggressive subtype that most commonly evolves from preexisting PC which does not respond to hormone the...

Full description

Bibliographic Details
Main Authors:	Mijović Milica, Ćorac Aleksandar, Smiljić Sonja, Savić Slađana, Mandić Predrag, Vitković Leonida, Leštarević Snežana, Janićijević-Hudomal Snežana
Format:	Article
Language:	English
Published:	Military Health Department, Ministry of Defance, Serbia 2019-01-01
Series:	Vojnosanitetski Pregled
Subjects:	prostatic neoplasms neuroendocrinology prostatespecific antigen risk factors neoplasm staging; prognosis
Online Access:	http://www.doiserbia.nb.rs/img/doi/0042-8450/2019/0042-84501800019M.pdf

Similar Items

Transrectal versus transperineal 14-core prostate biopsy in detection of prostate cancer: A comparative evaluation at the same Institution
by: Maria Angela Cerruto, et al.
Published: (2014-12-01)

Prostate-specific antigen and free prostate-specific antigen/prostate-specific antigen ratio in patients with benign prostatic hyperplasia and prostate cancer
by: Amal A. Hussein, et al.
Published: (2020-12-01)

Focal neuroendocrine differentiation in prostatic gland carcinoma with basaloid pattern
by: Gligorijević Jasmina V., et al.
Published: (2011-01-01)

Neuroendocrine differentiation in prostate cancer
by: Cerović Snežana J., et al.
Published: (2004-01-01)

Advanced prostatic carcinomas with low serum levels of prostate-specific antigen
by: Cerović Snežana J., et al.
Published: (2002-01-01)

Specificity and sensitivity of preoperative total serum prostate specific antigen in diagnosis most common histopathological change of prostate
by: Mijović Milica, et al.
Published: (2017-01-01)

Correlation between prostate-specific antigen and histopathological difference of prostate carcinoma
by: Živković Slađana
Published: (2004-01-01)

The relation of serum PSA and Gleason's grade in patients with prostacic carcinoma
by: Živković Slađana, et al.
Published: (2003-01-01)

Certainty in an uncertain world: A clinicians' viewpoint of sensitivity and precision
by: Twomey Patrick J.
Published: (2008-01-01)

Value of prostate specific antigen in predicting the existence of bone metastasis in scintigraphy
by: Ernani L. Rhoden, et al.
Published: (2003-04-01)

Initial Symptomatic Pituitary Metastasis in a Patient with Prostate Foamy Gland Carcinoma: Tailoring Safe and Effective Therapy
by: Marin Prpić, et al.
Published: (2015-01-01)

Outcomes following negative prostate biopsy for patients with persistent disease after radiotherapy for prostate cancer
by: Jacob H. Cohen, et al.
Published: (2010-02-01)

Predictive value of PSA velocity over early clinical and pathological parameters in patients with localized prostate cancer who undergo radical retropubic prostatectomy
by: Martinez Carlos A.L., et al.
Published: (2004-01-01)

Are prostate carcinoma clinical stages T1C and T2 similar?
by: Athanase Billis, et al.
Published: (2006-04-01)

Assessment of serum level of prostate-specific antigen adjusted for the transition zone volume in early detection of prostate cancer
by: Marcos D. Ferreira, et al.
Published: (2005-04-01)

Metastatic prostate cancer in the modern era of PSA screening
by: Philip A. Fontenot Jr, et al.

Review of Clinical Manifestations of Biochemically-advanced Prostate Cancer Cases
by: Edmund Chiong, et al.
Published: (2005-07-01)

Elevated prostate volume index and prostatic chronic inflammation reduce the number of positive cores at first prostate biopsy set: results in 945 consecutive patients
by: Antonio B. Porcaro, et al.

DIAGNOSIS OF PROSTATIC NEOPLASM LATER TO ANTIBIOTIC TREATMENT IN PATIENTS WITH PROSTATE-SPECIFIC ANTIGEN BETWEEN 4 AND 10 ng/ml (IN SPANISH)
by: Infantes-Burgos Ronald Javier, et al.
Published: (2014-01-01)

Can Single Positive Core Prostate Cancer at biopsy be Considered a Low-Risk Disease after Radical Prostatectomy?
by: Ricardo Kupka da Silva, et al.
Published: (2013-12-01)

Predictive value of [-2]propsa (p2psa) and its derivatives for the prostate cancer detection in the 2.0 to 10.0ng/mL PSA range
by: I. Vukovic, et al.

Integrated predictive model for prostatic cancer using clinical, laboratory and ultrasound data
by: GUSTAVO DAVID LUDWIG, et al.

Prostate-Specific Antigen fluctuation: what does it mean in diagnosis of prostate cancer?
by: Jun Seok Kim, et al.
Published: (2015-04-01)

Does index tumor predominant location influence prognostic factors in radical prostatectomies?
by: Athanase Billis, et al.

Retrospective study comparing six - and twelve-core prostate biopsy in detection of prostate cancer
by: Motoi Tobiume, et al.
Published: (2008-02-01)

PSA kinetics before 40 years of age
by: Cristiano Linck Pazeto, et al.

Biochemical recurrence after radical prostatectomy: what does it mean?
by: Rafael Tourinho-Barbosa, et al.

Is It Effective to Perform Two More Prostate Biopsies According to Prostate-Specific Antigen Level and Prostate Volume in Detecting Prostate Cancer? Prospective Study of 10-Core and 12-Core Prostate Biopsy
by: Byung Il Yoon, et al.
Published: (2012-05-01)

Neuroendocrine control of water balance in the decapod crustacean, Thalamita crenata
by: Tullis, Richard E
Published: (2009)

Evaluation of concordance between histopathological prognostic findings from prostate needle biopsy samples and serum prostate-specific antigen levels
by: Cengiz Kocak
Published: (2019-03-01)

Analysis of risk factors of involvement of seminal vesicles in patients with prostate cancer undergoing radical prostatectomy
by: Marcos F. Dall'Oglio, et al.
Published: (2004-12-01)

A new nomogram to predict pathologic outcome following radical prostatectomy
by: Alexandre Crippa, et al.
Published: (2006-04-01)

Prostate-specific antigen and prostate-specific antigen density cutoff points among Indonesian population suspected for prostate cancer
by: Ahmad Anies Shahab, et al.
Published: (2013-03-01)

A case report of prostate cancer metastasis to the stomach resembling undifferentiated-type early gastric cancer
by: Chiaki Inagaki, et al.
Published: (2017-08-01)

Influence of repeated prostate-specific antigen screening on treatment pattern in a country with a limited social perception of prostate cancer: Korean national wide observational study
by: Young Hwii Ko, et al.
Published: (2021-05-01)

Correlation between Gleason score distribution and Prostate Health Index in patients with prostate-specific antigen values of 2.5–10 ng/mL
by: Joongwon Choi, et al.
Published: (2020-11-01)

Metastatic bone lesions of men in combination with an increase in serum PSA from the point of view of diagnosing carcinomas of unknown primary localization
by: O. V. Poslavska, et al.
Published: (2019-05-01)

Targeted next-generation sequencing for locally advanced prostate cancer in the Korean population
by: Jungyo Suh, et al.
Published: (2020-03-01)

Racial influence on the prevalence of prostate carcinoma in Brazilian volunteers
by: Edson L Paschoalin, et al.
Published: (2003-08-01)

Prostate cancer pathologic stage pT2b (2002 TNM staging system): does it exist?
by: Maisa M. Quintal, et al.
Published: (2006-02-01)